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Available online 20 October 2016Background: Coccidioidomycosis is an endemic fungal infection foundmost commonly in the Southwestern Unit-
ed States, NorthwesternMexico, and parts of Central and South America. Although infection is relatively uncom-
mon during pregnancy, it is imperative to have an index of suspicion in order to diagnose and begin timely
treatment to prevent dissemination and dire consequences.
Case report: A 33-year-old Hispanic female was evaluated after she was involved in an automobile accident. Ra-
diographic evaluation showed a 3.2 × 3.2 cm cavitary thick-walled lesion. A biopsy was negative for malignancy.
Evaluation was positive for coccidioidomycosis by complement ﬁxation reaction. Four months later, the patient
presented 7 weeks into a pregnancy with massive hemoptysis. Bronchoscopy revealed bleeding from the right
upper lobe and emergency embolizationwas performed. The patient had a spontaneous abortion 9 days after ad-
mission. The right upper and middle lobes of the lung were resected due to continuous bleeding. A subsequent
pregnancy was un-eventful. Coccidioidomycosis titers remained negative throughout the second pregnancy.
Discussion: This case demonstrates the potential for severe pulmonary coccidioidomycosis and vascular strain of
pregnancy-associated vascular expansion in the ﬁrst trimester of pregnancy and the possibility of a favorable
pregnancy outcome in subsequent pregnancies after appropriate treatment. The route of feto-maternal transmis-
sion and placental lesions in coccidioidomycosis are discussed.
© 2016 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
Coccidioidomycosis
Pregnancy
Placental lesions1. Introduction
Coccidioidomycosis also known as Valley Fever, is an infection
caused by the fungi of the genus Coccidioides [1]. Coccidioides spp. are
dimorphic, soil-dwelling fungi known to cause a broad spectrum of
symptoms ranging from amild febrile illness to severe pulmonaryman-
ifestations or disseminated disease [2,3]. The genus Coccidioides is com-
prised of two genetically distinct species: C. immitis and C. posadasii [4].
These two species cause similar clinical symptoms, however they are
present in different geographic regions. C. immitis is found in central
and southern California, with the San Joaquin Valley being the regionedicine, Texas Tech University
treet, Odessa, TX 79763, USA.
, Department of Obstetrics and
r at the Permian Basin, 501 W.
Flores-Guardado),
h).
pen access article under the CC BY-Nof greatest endemicity [3]. Themost concentrated region for C. posadasii
is in Arizona and sporadic sites in southern Utah and Nevada. Outside
the U.S., C. posadasii is present in parts of Mexico and Central and
South America [3,4]. Cases of coccidioidomycosis in pregnancy are rare
and were extensively described in a review by Crum and Ballon-Landa
[5]. Maternal and fetal mortality, associated with the disseminated dis-
ease, is high. Medical pregnancy termination has been advised when
disseminated infection is detected in early pregnancy [6,7]. Recent re-
ports showed discrepancies between Coccidioidomycosis-related peri-
natal mobility and mortality and the disease-associated placental
lesions. Here, we report a case of coccidioidomycosis in a woman with
a non-viable pregnancy with a subsequent unaffected pregnancy and
non-speciﬁc placental lesion. A literature review of placental ﬁndings
associated with coccidioidomycosis cases, published since 1948, is
provided.
2. Case report
A 30-year-old Hispanic female with an intrauterine pregnancy at
7 weeks of gestation was admitted to the hospital with mildC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
6 H. Labuschagne et al. / Case Reports in Women's Health 12 (2016) 5–10hemoptysis, which evolved into massive bleeding during hospitaliza-
tion. The patient was diagnosed with pulmonary coccidioidomycosis
four months earlier. This initial diagnosis was made after a chest X-ray
and CT scan performed due to trauma (car accident). The evaluation re-
vealed a 3.2 × 3.2 cm thickwalled cavitary lesion in the right upper lobe.
A CT guided biopsy was performed and was negative for malignancy.
Serum analyses of Coccidioides antibodies by Complement Fixation
(CF) were positive (1:32). The patient was prescribed ﬂuconazole,
which she discontinued after two weeks. At the subsequent admission
four months later, the patient complained of blood tinged sputum
(20–35 ml at a time, 2–3 times per day) and productive cough for
3 days. She denied shortness of breath, night sweats, chills, fever, sore
throat, chest pain, wheezing, loss of weight or appetite, and nausea or
vomiting. The medical history was remarkable for a 15-years history
of type I Diabetes Mellitus on insulin. The patient lived in West Texas
and had no recent travel history. Her last PPD was 15 years prior with
no history of TB exposure.2.1. At physical examination
At the physical examination, the patient had a temperature of 98.7°F,
a pulse rate 108 beats/min, systolic/diastolic BP of 146/92 mm Hg, and
oxygen saturation of 97% on room air. The auscultation revealed coarse
breath sounds over right upper lobe. Neither visible skin lesions, nor
palpable lymph nodes were noted.2.2. Laboratory data
The complete blood count showed leukocytosis (WBC 11.8 × 103 μl
with polymorphs 72%), Hb 14.1 g/dl, platelet count of 279 × 103/μl,
and an eosinophil count within the normal range. The complete meta-
bolic panel was unremarkable, except Hb A1C was 9.3%. Urine analysis
showed 12 WBC/hpf, 4 RBC/hpf, protein 50 mg/dl, 500 leucocytes/ul,
and βhCG 8715 mIU/ml. Sputum cultures and smear were negative for
acid-fast bacilli (AFB). A serum fungal panel was positive for coccidioi-
domycosis antibodies only. Coccidioidomycosis CF titer was 1:4, IgG
2:1, IgM 1:5. Chest radiography ﬁndings were unchanged compared to
the prior radiograph. A transvaginal ultrasound showed an intrauterine
pregnancy with a 6.5 week fetal pole with no fetal heartbeat.2.3. Hospital course
Three days after admission, the patient's hemoptysis worsened
(N240 ml/24 h), she developed sinus tachycardia and shortness of
breath and was transferred to the ICU. A bronchoscopy revealed a
localized hemorrhage in the right upper lobe and an emergency embo-
lization of the right bronchial arterywas performed. After the emboliza-
tion, the patient's hemoptysis was temporarily controlled (20–
30 ml/24 h). Fluconazole was initiated on the fourth day after a multi-
disciplinary discussion of optimal treatment. On the ninth day of the ad-
mission, the patient had a spontaneous abortion. The following day
60 ml expectoration of blood in one sitting was noticed. A right upper
and middle lobe lobectomy was performed. The patient recovered and
was subsequently discharged 16 days after admission. Oral ﬂuconazole
was continued at discharge. The patient received instructions to follow
up regularly at an infectious diseases clinic as an outpatient and empha-
siswas placed on strict adherence tomedication and contraception. Flu-
conazole was continued for one year. A follow up chest CT revealed no
active lymphnodes or inﬁltrates. Eightmonths later, the patient became
pregnant. Coccidioidomycosis antibody complement ﬁxation titer
remained negative throughout the pregnancy. An elective cesarean sec-
tion was performed at 37 weeks (due to 2 previous cesarean sections)
without any complications. The placenta was collected and evaluated.2.4. Placental evaluation
2.4.1.
The placenta was collected after delivery and was either parafﬁn-
embedded for immunohistochemistry or ﬂash-frozen in liquid nitrogen
for Quantitative Polymerase chain reaction (Q-PCR). DNA was isolated
from the placenta tissues,membrane, and cord using aWizard Genomic
DNA Puriﬁcation kit (Promega, Madison, WI, USA). The DNA samples
were than analyzed using the absolute quantiﬁcation real-time PCR
method. Samples were run with FastStart Essential DNA Green Master
mix (Roche, Indianapolis, IN, USA) and commercially available primers
and controls: β-actin [8] and Coccidioides species [9]. The assays were
performed in triplicate. A standard curve was prepared from dilutions
of a Coccidioides immitus control DNA (Vircell, Granda, Spain). The dilu-
tions used to make the standard curve were 60,000 copies/rxn, 6000
copies/rxn, 600 copies/rxn, and 60 copies/rxn. The placental tissue sam-
ples were negative for Coccidioides immitus DNA (Fig. 1).
2.4.2. Pathological evaluation
The placental weight was 500 g. Pathological evaluation of the pla-
centa revealed foci of calciﬁcation (Fig. 2A), increased number of syncy-
tial knots (Fig. 2B), edematous villi (Fig. 2C) and necrosis (Fig. 2D).
3. Discussion
Coccidioidomycosis is caused by Coccidioides immitis or C. posadasii,
endemic to the Southwestern United States, northwestern parts ofMex-
ico, Central and South America [10]. The exact incidence of coccidioidal
infections is difﬁcult to calculate because approximately 60% of infected
individuals are asymptomatic or have subclinical disease and never seek
medical attention. An estimated 150,000 infections occur annually in
the United States [11]. The incidence of coccidioidal infections in Arizo-
na, Nevada, California, New Mexico, and Utah has increased from 5.3
per 100,000 in 1988 to 42.6 per 100,000 in 2011 [12]. Around 75,000
deaths per year result from the infection. This increase in the disease
occurrence requires particular attention in the pregnant population,
since the consequences could manifest not only in the dissemination
of coccidioidomycosis, but also result in fetal disease, congenital anom-
alies and other developmental sequels [5]. Despite the fact that
coccidiomycosis has been more common among men than women
(55–66% of cases collected from surveillance data from Arizona
(1993–2006) involved men), pregnant women experience dissemina-
tion 40–100 times more frequently than men [13–15]. Pregnancy alters
thematernal immune systemwhich potentially increases maternal and
fetal vulnerability to common viral and parasitic infections [16]. The
consequences could be far greater for women, than for men. The usual
route of Coccidioides transmission is through inhalation of spores that
are found in the soil of endemic areas. Spores get lodged in the lungs
and produce spherules [17]. After infection, awide spectrumofmanifes-
tations is possible. Early symptoms such as cough, fever, and arthralgia
are fairly common. Primary infectionsmost commonlymanifest as com-
munity-acquired pneumonia approximately 7–21 days after exposure.
Complications of coccidioidomycosis include severe pneumonia with
respiratory failure and bronchopleural ﬁstulas requiring resection,
lung nodules, and dissemination. Dissemination may be rapid with
fatal consequences. Any organof the body can be involved in dissemina-
tion, but Coccidioides species have an afﬁnity for the lungs, skin, soft tis-
sue, joints, brain, and especially the meninges. Hemoptysis may occur
and suggests the development of a pulmonary cavity. Cavities present
in approximately 2 to 8% of adults infected with a Coccidioides species.
Pregnantwomen are at a higher risk for dissemination and re-activation
of the infection [18], however not all pregnant women who develop
coccidioidomycosis are at risk for dissemination –Wack et al. [3] report-
ed only 10 cases of coccidioidomycosis in 47,120 pregnancies in an en-
demic area of Arizona in 1988 (2.1 cases per 10,000 pregnancies). Only 2
Fig. 2. (A)Microphotographs of the placenta, demonstrating villous calciﬁcation shown at 100×magniﬁcation, (B) increased number of syncytial knots shown at 100×magniﬁcation, (C)
edematous villi shown at 100× magniﬁcation, and (D) necrosis (arrows) shown at 40× magniﬁcation.
Fig. 1. A. Melting curve forβ-actin (pink color,melting temperature 87.5 °C) and Coccidioides spp. (blue color,melting temperature 85.5 °C.) in the control DNA samples, placental samples
(placenta, attached to placenta umbilical cord, fetalmembranes) and soil samples. Note: placental samples donot show speciﬁc ampliﬁcation.B. Standard curve for quantifying Coccidiosis
spp. that was created by using 4 standards with the following dilutions: 60,000 copies/rxn, 6000 copies/rxn, 600 copies/rxn, and 60 copies/rxn.
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Table 1
Reported in the literature cases of coccidioidomycosis with available information regarding placental evaluation in human and animal studies.
Age
Time of
Diagnosis
Disseminated
sites of
disease in
article Titer Treatment Fetal outcome Placenta gross and micro description
Maternal
outcome
Geographic
area Strain Reference
20 Day of
delivery
Yes 1:64 Amphotericin B,
postpartum
Infected infant Multiple foci of acute inﬂammation with numerous Coccidoides spherules. Fatal San
Francisco,
CA
C.
Imittis
[18]
38 34 weeks Disease
reactivation
during
pregnancy
1:04 Amphotericin IV Healthy infant Normal placenta, weighed 310 g at 36 weeks. Recovered NR C.
Imittis
[17]
30 18–19 weeks NR 1:16 Fluconazole Healthy infant Unremarkable Recovered Recent
travel to
Arizona and
Mexico
C.
Imittis
[6]
N/A N/A N/A N/A N/A N/A 16 cases of placentitis in association with 35 cases of maternal death Fatal N/A N/A [19]
34 16 weeks During
pregnancy
NR NR Fetal death Many caseous areas scattered through the placenta, otherwise there were no lesions. Fatal,
20 weeks
gestation
California NR [21]
22 20 weeks During
pregnancy
NR NR Premature birth, death at
age 1 month
Necrotic, purulent and caseous lesions, ﬁlled with spherules, some large spherules
contained encapsulated endospores. No inﬂammatory lesions were in the umbilical
cord.
Fatal, two
weeks after
birth
Kern County,
CA
C.
imittis
[21]
NR 30 weeks During
pregnancy
NR Daily
amphotericin B
Healthy infant Placental weighed 530 g, several small intravenous thrombi, and minor areas of
necrosis those were ﬁrm. These white areas contained dead villi enmeshed dense
ﬁbrin deposits and isolated edematous reactions to Coccidioides. Numerous typical
Coccidioides were present without inﬂammatory proliferation.
Labor induced Area
endemic for
Coccidioides
NR [22]
34 24 weeks Two years
prior to
pregnancy
1:256
after
delivery
Daily
amphotericin B
Healthy infant Occasional necrotic foci with Coccidioides Recovered Contracted
in Arizona
NR [22]
30 20 weeks Diagnosed
during
pregnancy
NR NR Fetal death Zones of necrosis, subacute inﬂammation. The zones in which spores were found are
localized by heavy deposit of ﬁbrin and blood platelets, ﬁlling the intervillous space.
Within this zone, chorionic villi were necrotic, but those with C. Imittis spherules were
viable. Ephithelioid and giant cell reaction.
Fatal Wyoming,
Colorado
C.
Imittis
[23]
N/A Third
trimester
N/A N/A N/A N/A Placentas were infected with coccidioidomycosis in all 6 cases of maternal death Fatal N/A N/A [24]
34 Preterm
birth
During
pregnancy
NR NR Twins; one died at age
11 days, the other died at
age 21 days
No lesions Fatal Riverside, CA NR [25]
34 At term During
pregnancy
NR NR Healthy infant, titer 1:4 No granulomas Reported with
4 cases of
maternal
Kern County,
CA
NR [26]
8
H
.Labuschagne
etal./Case
Reports
in
W
om
en's
H
ealth
12
(2016)
5–10
death
20 16 weeks During
pregnancy
1:128 NR Delivered by postmortem
C-section, death after 10 h
Marked focal acute and chronic granulomatous inﬂammation containing spherules
and endospores Coccidioides immitis.
Fatal Arizona C.
immitis
[27]
27 Postmortem During
pregnancy
1:128 NR Preterm labor, healthy
infant
Placenta weighed 359 g, had necrosis, acute inﬂammation, presence of the spherules.
The area between necrotic lesions was normal
Fatal Arizona NR [28]
27 26 weeks During
pregnancy
NR Amphotericin B,
vancomycin, and
voriconazole
Fetal death at 26 weeks Coagulative necrosis of chorionic villi and an intense inﬁltration by neutrophils,
lymphocytes, and plasma cells in the intervillous space. Spherules ﬁlled with round
fungal endospores and scattered individual sporangiospores of Coccidioides were
identiﬁed adjacent to areas of placental infarction. Fetal membranes and umbilical
cord were without signiﬁcant inﬂammation. A 500 ml retroplacental hemorrhage
(abruption) was found at the time of emergent cesarean section.
Recovered California NR [29]
34 20 weeks During
pregnancy
Actidone NR Healthy infant delivered
at term, titer 1:2
No pathologic evidence of coccidioidal granuloma of the placenta Recovered NR NR [30]
22 20 weeks NR NR NR Death at age 6 weeks Numerous large and small lesions, both in the decidua and in the chorionic villi. The
lesions were necrotic, come appearing caseous, others frankly purulent. These lesions
were ﬁlled with spherules of Coccidioides immitis. Spherules were of all sizes and
stages of development. Some large spherules contained encapsulated endospores.
Fatal Kern County,
CA
C.
Immitis
[30]
N/A Third
trimester
N/A N/A N/A N/A No description of granulomas in 11 cases of disseminated Coccidioidomycosis N/A Kern County,
CA
N/A [30]
38 32 weeks NR NR NR Healthy infant, weighed
2381 g.
Grossly normal, at microscopic examination contained Coccidioides immitis. Fatal NR C.
Immitis
[31]
22 18 weeks During
pregnancy
1:128 Amphotericin B
lipid complex
(ABLC)
Premature birth at
25 weeks, had
coccidioidomycosis, died
at age 34 days
Multiple granulomas and large numbers of Coccidioides organisms. Abundant numbers
of C. Immitis grew from placental and cervical cultures.
Recovered Long Beach,
CA
C.
Immitis
[32]
21 24 weeks During
pregnancy
NR Metacortin Fetal death at 24 weeks in
utero
Normal placenta Fatal Fort Bliss, TX C.
Immitis
[33]
21 28 weeks During
pregnancy
NR Amphotericin
after delivery
Healthy infant delivered
preterm at 32 weeks
Normal placenta Fatal New
Orleans,
moved from
Arizona
C.
Immitis
[34]
37 24 weeks During
pregnancy
1:8 Amphotercin B Healthy infant delivered
at 38 weeks
Three areas of infarction (b2 cm in diameter), moderate intervillous ﬁbrin deposition,
numerous fungal spherules containing endospores and foreign body giant cells, acute
inﬂammatory reaction, focal infarction with necrosis.
Recovered New Mexico NR [35]
19 37 weeks During
pregnancy
NR NR Healthy infant, labor
induced at 37 weeks
Multiple coccidioidomycosis micro-abscesses Fatal Central
California
NR [4]
Animal report
N/A N/A Alpaca
(Vicugna
pacos)
1:256 N/A Death Many irregular, roughly round (~1–2 cm diameter) areas of hyperemia and
hemorrhage covered by a ﬁbrinous exudate on the chorionic and allantoic surfaces.
Euthanized Southern
California
N/A [20]
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10 H. Labuschagne et al. / Case Reports in Women's Health 12 (2016) 5–10of the 10 patients developed systemic illness that presented as fevers,
pulmonary inﬁltrates and meningitis.
In a recent study of 32 cases of coccidioidomycosis in pregnant
women residing in Kern County, California, dissemination developed
in 3 women [19]. The risk of dissemination increases as the weeks of
gestation advance, with the third trimester and immediate postpartum
period having the highest risk. The mechanism of increased risk might
be associated with depressed cellular immunity or changes in 17β-es-
tradiol and progesterone levels, which enhance the maturation and
growth of C. immitis [20–22]. The question regarding the transplacental
passage of the spherules is controversial [23–26]. The spherules were
found in the placenta (Table 1) and documented to destroy the villi,
however sporules were not found in fetal circulation [20]. The patho-
gnomonic features of coccidioidomycosis in the placenta and the ab-
sence of inﬂammatory response were described by McCafee and
Benirschke [20]: “Coccidioides organismswere located in occasionalmi-
croscopic foci of necrosis without inﬂammatory cell proliferation. Al-
though this kind of bland necrotizing change is also characteristic of
herpes simplex placentitis, the two diseases are differentiated by the
morphologic features of the respective organisms.” Taking into consid-
eration multiple placental lesions, found in the cases of maternal
coccidiomycosis, it was suggested that placental insufﬁciency might
contribute to fetal demise [27]. In the reviewed cases of placental le-
sions, acute placental inﬂammatory response was reported in three
cases with the fatal outcome. Increased ﬁbrin deposition is a common
placental lesion associated with this disorder (Table 1).
This ﬁbrin deposition is part of the pathogenesis of coccidiomycosis:
a ﬁbrillar material, released by endospores, inhibits polymorphonuclear
cell access to the emerging endospores [28]. The non-permissiveness of
the placenta to coccidiomycosis was also explained by the characteristic
thrombotic segregation of the organism, which may “eliminate viable
capillaries” and thus prevent transmission to the fetus [29,30]. The pla-
cental lesions described in present case where non-speciﬁc for
coccidiomycosis.
While the causative relationship between coccidioidomycosis and
pregnancy loss cannot be determined, Coccidioides posadasii and immitis
has been associated with abortion in animal examples [27,31]. African
Americans, Filipinos, and Hispanics are known to be at higher risk for
dissemination. In the present case, the patient had at least three risk fac-
torsmaking hermore susceptible to a severe formof infection –Hispan-
ic race, pregnancy, and diabetes. Treatments for coccidioidomycosis
depend on the severity of the disease, presence of dissemination, and
the site involved. Amphotericin B deoxylate, azoles, or both are available
as treatment options. Amphotericin B deoxylate is considered to be the
safest during pregnancy (category B). Lipid preparations of Amphotericin
B are preferred over amphotericin deoxylate due to reduced toxicity.
Azoles have been used as treatment for coccidioidomycosis for over
20 years, however soon after their introduction it became evident that
Azoles might be teratogenic [32]. Currently, ﬂuconazole is a category D
drug. The patient in the presented case was reinitiated on ﬂuconazole as
her pregnancy was considered to be nonviable during her admission at
early gestation, indeed this pregnancy resulted in spontaneous abortion.
Women with a history of resolved pulmonary coccidioidomycosis
have a minimal risk of disease reactivation during pregnancy, whereas
in women with a history of disseminated coccidioidomycosis this
risk is increased [18]. In agreement with the later observation, in
the presented case the second pregnancy was not associated with
reactivation of the disease and placental lesions were nonspeciﬁc
for coccidioidomycosis.
In conclusion, the described case demonstrates the potential for se-
vere pulmonary coccidioidomycosis and vascular strain of pregnancy-associated vascular expansion in the ﬁrst trimester of pregnancy and
the possibility of a favorable pregnancy outcome in subsequent preg-
nancies after appropriate treatment.References
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